Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Nearly 30 years of experience in the Korean/Asian equity research. Major sectors coverage include the following:
- Technology 
- Consumer 
- Special Situations/Deep Value Plays
- Tender Offers/M&As
- Holdcos/Stubs
- Asian Unicorns/Private Companies

Korea/Asia, Events, IPOs

Equity Capital Markets

<ul>
<li>
<strong>Neofect is one of the most intriguing health care related small cap IPOs in Korea in 2018. The Neofect IPO </strong><strong>is expected completed in November that is sure to receive a lot of attention, despite recent difficult market conditions. Neofect develops AI powered rehabilitation related products and solutions to help patients with with neurological and musculoskeletal injuries.</strong> </li>
<li>The company recently won some globally recognized awards in the past couple of years. For example, its Rafael Smart Glove won the CES 2017 Innovation Award and AARP (American Retirement Association) 2017 Innovation Champion Award. Its Raphael Smart Pegboard won the CES innovation award in 2018. About 700 patients already use the company's AI based home rehabilitation service. </li>
<li>Neofect has been approved by the Korea Exchange for the KOSDAQ listing under the "technology exception policy," which has allowed companies such as Neofect to be listed despite the fact that the company generates only a small amounts of revenue right now.  The IPO price range is between 10,000 won to 12,500 won. The institutional investors bookbuilding starts on November 12th. According to the bankers' valuation, the expected market cap after the IPO is expected to be between 122 billion won and 153 billion won. The IPO base deal size is between US$16 million and US$20 million. </li>
</ul>



Neofect is one of the most intriguing health care related small cap IPOs in Korea in 2018. The Neofect IPO is expected completed in November that is sure to receive a lot of attention, despite recent difficult market conditions. Neofect develops AI powered rehabilitation related products and solutions to help patients with with neurological and musculoskeletal injuries. 
The company recently won some globally recognized awards in the past couple of years. For example, its Rafael Smart Glove won the CES 2017 Innovation Award and AARP (American Retirement Association) 2017 Innovation Champion Award. Its Raphael Smart Pegboard won the CES innovation award in 2018. About 700 patients already use the company's AI based home rehabilitation service. 
Neofect has been approved by the Korea Exchange for the KOSDAQ listing under the "technology exception policy," which has allowed companies such as Neofect to be listed despite the fact that the company generates only a small amounts of revenue right now.  The IPO price range is between 10,000 won to 12,500 won. The institutional investors bookbuilding starts on November 12th. According to the bankers' valuation, the expected market cap after the IPO is expected to be between 122 billion won and 153 billion won. The IPO base deal size is between US$16 million and US$20 million. 


Neofect IPO Preview (Part 1): AI + Innovative Rehab Solutions = Kaching $$$

NEOFECT Co Ltd

Neofect IPO Preview (Part 1): AI + Innovative Rehab Solutions = Kaching $$$